Prepare the Injection Site Cleanse the selected injection site with an alcohol swab and allow it to dry completely before injecting the medication
Association of tramadol vs codeine prescription dispensation with mortality and other adverse clinical outcomes
Our patients rate our online doctor service as excellent on Trustpilot
A 2020 review of 12 studies indicated that berberine led to a significant reduction of body weight, BMI and other markers
However, it supports the cellular health and liver function that allow testosterone therapy to work optimally
10 / 2026 Zealand Pharma announces Boehringer Ingelheim's novel glucagon/GLP-1 dual agonist survodutide achieved significant weight loss of 16.6% delivering meaningful metabolic improvement in people living with obesity or overweight in Phase 3 trial In SYNCHRONIZE-1, participants lost up to an average of 39.2 lb (17.8 kg) from baseline after 76 weeks of treatment with survodutide, a glucagon/GLP-1 receptor dual agonist1 The trial met both weight loss primary endpoints and its key secondary endpoint evaluating waist circumference, a predictor of cardiometabolic risk, together demonstrating survodutide's potential to broadly improve metabolic health1 In addition to these positive results, Boehringer is advancing its broad metabolic health R&D program, exploring multiple pharmaceutical approaches to weight management including oral treatments
